Early-Career Researcher Resource Center
Recent articles
News, perspectives and resources to help navigate the early stages of your neuroscience career
FEATURED
Frameshift: How Mia Thomaidou tapped a fellowship to connect neuroscience to criminal justice
How to teach programming in the age of AI
‘Friction-maxxing’ in school: Students should read primary literature, not AI summaries
RESOURCES
Early-career researcher action potentials
News and perspectives
The ‘secretly awesome’ side of a teaching career
European Research Council backtracks on stricter grant resubmission rules
Scientists push back against stricter European Research Council grant application rules
What neuroscientists want from a new NINDS director
Frameshift: How Caitlin Vander Weele made science communication her business
Securing the academic pipeline amid uncertain U.S. funding climate
Let’s teach neuroscientists how to be thoughtful and fair reviewers
Frameshift: Raphe Bernier followed his heart out of academia, then made his way back again
Frameshift: At a biotech firm, Ubadah Sabbagh embraces the expansive world outside academia
As chief of staff at Arcadia, Ubadah Sabbagh gets to do science while also pushing the boundaries of how science gets done.
Frameshift: At a biotech firm, Ubadah Sabbagh embraces the expansive world outside academia
As chief of staff at Arcadia, Ubadah Sabbagh gets to do science while also pushing the boundaries of how science gets done.
Neuroscience’s leaders, legacies and rising stars of 2025
Here are seven stories from the past year about some of the field’s most engaging figures.
Neuroscience’s leaders, legacies and rising stars of 2025
Here are seven stories from the past year about some of the field’s most engaging figures.
Talking shop: The Transmitter’s top quotes of 2025
Find out what “may be one of the brain’s most underappreciated superpowers” and why it’s so crucial to “talk about our research in our everyday lives.”
Talking shop: The Transmitter’s top quotes of 2025
Find out what “may be one of the brain’s most underappreciated superpowers” and why it’s so crucial to “talk about our research in our everyday lives.”
Frameshift: Shari Wiseman reflects on her pivot from science to publishing
As chief editor of Nature Neuroscience, Wiseman applies critical-thinking skills she learned in the lab to manage the journal’s day-to-day operations.
Frameshift: Shari Wiseman reflects on her pivot from science to publishing
As chief editor of Nature Neuroscience, Wiseman applies critical-thinking skills she learned in the lab to manage the journal’s day-to-day operations.
The Transmitter ’s Rising Stars of Neuroscience 2025
We recognize the outstanding achievements of 25 neuroscientists who stand to shape the field for years to come.
The Transmitter ’s Rising Stars of Neuroscience 2025
We recognize the outstanding achievements of 25 neuroscientists who stand to shape the field for years to come.
Explore more from The Transmitter
Supported by a $40 million NIH grant, Yale brain shuttle technology raises questions
Yale University claims its STEP platform might be able to deliver gene-editing tools into the brain via multiple routes. Researchers are eager to see more.
Supported by a $40 million NIH grant, Yale brain shuttle technology raises questions
Yale University claims its STEP platform might be able to deliver gene-editing tools into the brain via multiple routes. Researchers are eager to see more.
What counts as a ‘naturalistic’ behavior?
Nedah Nemati explains how neuroscience methods and the lived experience of the scientists themselves shape how we define the behaviors we seek to explain.
What counts as a ‘naturalistic’ behavior?
Nedah Nemati explains how neuroscience methods and the lived experience of the scientists themselves shape how we define the behaviors we seek to explain.
Allen Institute sets sights on treatments for five brain diseases
The Brain Health Accelerator program aims to harness single-cell transcriptomics and cell-type-specific genetic tools to develop treatments for Alzheimer’s, Huntington’s and Parkinson’s diseases, Lewy body dementia and ALS.
Allen Institute sets sights on treatments for five brain diseases
The Brain Health Accelerator program aims to harness single-cell transcriptomics and cell-type-specific genetic tools to develop treatments for Alzheimer’s, Huntington’s and Parkinson’s diseases, Lewy body dementia and ALS.